What we did in this trial was integrate a new diagnostic test, a test that evaluates the expression of a panel of genes to see if we can identify or use it to assign therapy in situations where we knew chemotherapy was really beneficial or in situations where we knew that chemotherapy was not beneficial.

Joseph Sparano

Categorized in : Health

The vast majority of women were getting chemo after surgery to prevent breast cancer recurrence and now the pendulum is swinging back to less chemotherapy use, mainly because we know which are the patients who are most likely to benefit from chemotherapy.

health